![PeerView Endocrinology & Diabetes CME/CNE/CPE Audio Podcast artwork](https://is3-ssl.mzstatic.com/image/thumb/Podcasts113/v4/12/35/a6/1235a6f7-320a-db51-94c0-bbcbcd171dd6/mza_3933038130939089111.jpg/100x100bb.jpg)
George L. Bakris, MD - Show Me the Data: Improving Renal Outcomes With Glucose-Lowering Therapy in the Individualized Management of T2DM
PeerView Endocrinology & Diabetes CME/CNE/CPE Audio Podcast
English - December 04, 2020 23:00 - 20 minutes - ★★★ - 4 ratingsScience cme medical education cme credits peerview insession inreview endocrinology diabetes cne Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Go online to PeerView.com/RBT860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert in cardiometabolic health discusses the role and ability of SGLT2 inhibitors to improve renal outcomes in patients with T2DM and/or CKD. Upon completion of this activity, participants should be better able to: Outline the mechanism(s) of action and clinical potential of newer options in glucose-lowering therapy that have been shown to improve renal outcomes in patients with T2DM, Evaluate the clinical efficacy and safety of newer options in glucose-lowering therapy in patients with T2DM and/or CKD, Integrate newer glucose-lowering therapies to improve the management of patients with T2DM and/or CKD based on the latest clinical evidence.